High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields

被引:64
|
作者
Sciabola, Simone [1 ]
Stanton, Robert V. [1 ]
Mills, James E. [2 ]
Flocco, Maria M. [2 ]
Baroni, Massimo [3 ]
Cruciani, Gabriele [4 ]
Perruccio, Francesca [5 ]
Mason, Jonathan S. [6 ]
机构
[1] Pfizer Res Technol Ctr, Cambridge, MA 02139 USA
[2] Pfizer Global Res & Dev, Sandwich CT13 9NJ, Kent, England
[3] Mol Discovery Ltd, Pinner HA5 5NE, Middx, England
[4] Univ Perugia, Lab Chemometr, I-60123 Perugia, Italy
[5] Syngenta, CH-4332 Stein Ag, Switzerland
[6] Lundbeck AS, DK-25000 Copenhagen, Denmark
关键词
RESOLUTION CRYSTAL-STRUCTURE; FAVORABLE BINDING-SITES; COUPLED RECEPTOR; EFFICIENT DETECTION; KINASE INHIBITORS; FUNCTIONAL SITES; LIGAND COMPLEXES; DRUG DESIGN; DATA-BANK; SEQUENCE;
D O I
10.1021/ci9003317
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new computational algorithm for protein binding sites characterization and comparison has been developed, which uses a common reference framework of the projected ligand-space four-point pharmacophore fingerprints, includes cavity shape. and can be used with diverse proteins as no structural alignment is required. Protein binding sites are first described using GRID molecular interaction fields (GRID-MIFs), and the FLAP (fingerprints for ligands and proteins) method is then used to encode and compare this information. The discriminating power of the algorithm and its applicability for large-scale protein analysis was validated by analyzing various scenarios: clustering of kinase protein families in a relevant manner, predicting ligand activity across related targets, and protein-protein Virtual screening. In all cases the results showed the effectiveness of the GRID-FLAP method and its potential use in applications Such as identifying selectivity targets and tools/hits for new targets via the identification of other proteins with pharmacophorically similar binding sites.
引用
收藏
页码:155 / 169
页数:15
相关论文
共 50 条
  • [31] HIGH-THROUGHPUT SCREENING AND EXPLOITING MOLECULAR DIVERSITY
    SCHEIRER, W
    WERNER, G
    WARR, WA
    SILLS, MA
    HOMON, CA
    AGRO FOOD INDUSTRY HI-TECH, 1995, 6 (05): : 17 - 20
  • [32] HIGH-THROUGHPUT SCREENING AND EXPLOITING MOLECULAR DIVERSITY
    SCHEIRER, W
    CHIMICA OGGI-CHEMISTRY TODAY, 1995, 13 (09) : 14 - 17
  • [33] vsLab-An Implementation for Virtual High-Throughput Screening Using AutoDock and VMD
    Cerqueira, N. M. F. S. A.
    Ribeiro, J.
    Fernandes, P. A.
    Ramos, M. J.
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2011, 111 (06) : 1208 - 1212
  • [34] Identification of Novel Molecular Targets of Four Microcystin Variants by High-Throughput Virtual Screening
    Tapia-Larios, Claudia
    Mendoza, Ernesto Garcia
    Rubio-Armendariz, Maria Carmen
    Olivero-Verbel, Jesus
    APPLIED SCIENCES-BASEL, 2022, 12 (05):
  • [35] High-throughput single molecule screening of DNA and proteins
    Yeung, ES
    CHEMICAL RECORD, 2001, 1 (02): : 123 - 139
  • [36] Towards high-throughput screening of photosensitizing fluorescent proteins
    Rodriguez-Pulido, A.
    Cortajarena, A. L.
    Flors, C.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S91 - S91
  • [37] HIGH-THROUGHPUT STABILITY SCREENING OF INTEGRAL MEMBRANE PROTEINS
    Mlynek, Georg
    Nagy, Michael
    Kostan, Julius
    Kotov, Vadim
    Marlovits, Thomas C.
    Djinovic-Carugo, Kristina
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : E52 - E52
  • [38] High-throughput screening - Reliability issues in high-throughput screening systems
    Brandt, DW
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (02): : 30 - +
  • [39] ViewDock TDW: high-throughput visualization of virtual screening results
    Lau, Christopher D.
    Levesque, Marshall J.
    Chien, Shu
    Date, Susumu
    Haga, Jason H.
    BIOINFORMATICS, 2010, 26 (15) : 1915 - 1917
  • [40] Hits, leads and artifacts from virtual and high-throughput screening
    Shoichet, B.
    FEBS JOURNAL, 2008, 275 : 23 - 23